Sputum Cytological Atypia as a Predictor of Incident Lung Cancer in a Cohort of Heavy Smokers with Airflow Obstruction

Cancer Epidemiology Biomarkers and Prevention

Volumn 12, Issue 10, 2003, Pages 987-993

  Prindiville, Sheila A ^a   Byers, Tim ^a   Hirsch, Fred R ^a   Franklin, Wilbur A ^a   Miller, York E ^a,b   Vu, Kieu O ^a   Wolf, Holly J ^a   Barón, Anna E ^a   Shroyer, Kenneth R ^a   Zeng, Chan ^a   Kennedy, Tim C ^c   Bunn, Paul A ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Lung Cancer Institute of Colorado   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; CANCER INCIDENCE; CANCER RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DIETARY INTAKE; FEMALE; FRUIT; HUMAN; HUMAN CELL; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; PREDICTION; PRIORITY JOURNAL; SMOKING; SPUTUM CYTODIAGNOSIS; VEGETABLE; VITAMIN SUPPLEMENTATION;

ADULT; AGED; AIRWAY OBSTRUCTION; COHORT STUDIES; DIET; FEMALE; FRUIT; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; SMOKING; SPUTUM; VEGETABLES;

EID: 10744230430     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Jemal, A., Thomas, A., Murray, T., and Thun, M. Cancer statistics, 2002. CA Cancer J. Clin., 52: 23-47, 2002.
2. Henschke, C. I., Yankelevitz, D. F., Libby, D. M., McCauley, D., Pasmanteier, M., Altorki, N. K., Smith, J. P., and Miettinen, O. S. Early lung cancer action project: annual screening using single-slice helical CT. Ann. N. Y. Acad. Sci., 952: 124-134, 2001.
3. Petty, T. L., Tockman, M. S., and Palcic, B. Diagnosis of roentgenographically occult lung cancer by sputum cytology. Clin. Chest Med., 23: 59-64, 2002.
4. Hirsch, F. R., Franklin, W. A., Gadzar, A. F., and Bunn, P. A., Jr. Early detection of lung cancer: Clinical perspectives of recent advances in biology and radiology. Clin. Cancer Res., 7: 5-22, 2001.
5. Risse, E. J. K., Vooijs, G. P., and van't Hof, M. A. Diagnostic significance of "severe dysplasia" in sputum cytology. Acta. Cytol., 32: 629-634, 1988.
6. Saito, Y., Nagamoto, N., Ota, S., Sato, M., Sagawa, M., Kamma, K., Takahashi, S., Usuda, K., Endo, C., Imai, T., and Fujimura S. J. Thorac. Cardiovasc. Surg., 104: 401-407, 1992.
7. Tockman, M. S., Gupta, P. K., Myers, J. D., Frost, J. K., Baylin, S. B., Gold, E. B., Chase, A. M., Wilkinson, P. H., and Mulshine, J. L. Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells: a new approach to early lung cancer detection. J. Clin. Oncol., 6: 1685-1693, 1988.
8. Marcus, P., Bergstralh, E., Fagerstrom, R., Williams, D. E., Fontana, R., Taylor, W. F., Prorok, P. C. Lung cancer mortality in the Mayo Clinic Lung Project: impact of extended follow-up. J. Natl. Cancer Inst., 92: 1308-1315, 2000.
9. Hirsch, F., Prindiville, S., Miller, Y., Franklin, W., Dempsey, E., Murphy, J., Bunn, P., and Kennedy, T. Flourescence versus white-light bronchoscopy for detection of pre-neoplastic lesions: a randomized study. J. Natl. Cancer Inst., 93: 1385-1391, 2001.
10. Lippman, S. M., and Spitz, M. R. Lung cancer chemoprevention: an integrated approach. J. Clin. Oncol. 19: 74s-82s, 2001.
11. Mayne, S. T., Buenconsejo, J., and Janerich, D. T. Previous lung disease and risk of lung cancer among men and women nonsmokers. Am. J. Epidemiol., 149: 13-20, 1999.
12. Tockman, M. S., Anthonisen, N. R., Wright, E. C., and Donithan, M. G. Airways obstruction and the risk for lung cancer. Ann. Intern. Med., 106: 512-518, 1987.
13. Skillrud, D. M., Offord, K. P., and Miller, R. D. Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study. Ann. Intern. Med., 105: 503-507, 1986.
14. Anthonisen, N. R., Connett, J. E., Kiley, J. P., Altose, M. D., Bailey, W. C., Buist, A. S., Conway, W. A., Jr., Enright, P. L., Kanner, R. E., and O'Hara, P. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA, 272: 1497-1505, 1994.
15. Kuller, L. H., Ockene, J., Meilahn, E., and Svendsen, K. H. Relation of forced expiratory volume in one second (FEV1) to lung cancer mortality in the Multiple Risk Factor Intervention Trial (MRFIT). Am. J. Epidemiol., 132: 265-274, 1990.
16. Peto, R., Speizer, F. E., Cochrane, A. L., Moore, F., Fletcher, C. M., Tinker, C. M., Higgins, I. T., Gray, R. G., Richards, S. M., Gilliland, J., and Norman-Smith, B. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation. Am. Rev. Respir. Dis., 128: 491-500, 1983.
17. Kennedy, T. C., Proudfoot, S. P., Franklin, W. A., Merrick, T. A., Saccomanno, G., Corkill, M. E., Mumma, D. L., Sirgi, K. E., Miller, Y. E., Archer, P. G., and Prochazka, A. Cytopathological analysis of sputum in patients with airflow obstruction and significant smoking histories. Cancer Res., 56: 4673-4678, 1996.
18. Serdula, M., Coates, R., Byers, T., Mokdad, A., Jewell, S., Chavez, N., Mares-Perlman, J., Newcomb, P., Ritenbaugh, C., Treiber, F., and Block, G. Evaluation of a brief telephone questionnaire to estimate fruit and vegetable consumption in diverse study populations. Epidemiology, 4: 455-463, 1993.
19. Kennedy, T. C., Proudfoot, S. P., Piantadosi, S., Wu, L., Saccomanno, G., Petty, T. L., and Tockman, M. S. Efficacy of two sputum collection techniques in patients with air flow obstruction. Acta Cytol., 43: 630-636, 1999.
20. Cox, D. R. Regression models and life table. J. Royal Stat. Soc. B, 34: 187-220, 1972.
21. Ziegler, R. G., Mayne, S. T., and Swanson, C. A. Nutrition and lung cancer. Cancer Causes Control, 7: 157-177, 1996.
22. Wattenberg, L. W., Wiedmann, T. S., Estensen, R. D., Zimmerman, C. L., Steele, V. E., and Kelloff, G. J. Chemoprevention of pulmonary carcinogenesis by aerosolized budesonide in female A/J mice. Cancer Res., 57: 5489-5492, 1997.
23. Bunn, P. A., and Keith, R. L. The future of cyclooxegenase-2 inhibitors and other inhibitors of the eicosanoid signal pathway in the prevention and therapy of lung cancer. Clin. Lung Cancer, 3: 271-277, 2002.
24. Gridley, G., McLaughlin, J. K., Ekbom, A., Klareskog, L., Adami, H. O., Hacker, D. G., Hoover, R., and Fraumeni, J. F., Jr. Incidence of cancer among patients with rheumatoid arthritis. J. Natl. Cancer Inst., 85: 307-311, 1993.
25. Schreinemachers, D. M., and Everson, R. B. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology, 5: 138-146, 1994.
26. Paganini-Hill, A., Chao, A., Ross, R. K., and Henderson, B. E. Aspirin use and chronic diseases: a cohort study of the elderly. BMJ, 299: 1247-1250, 1989.
27. Thun, M. J., Namboodiri, M. M., Calle, E. E., Flanders, W. D., and Heath, C. W., Jr. Aspirin use and risk of fatal cancer. Cancer Res., 53: 1322-1327, 1993.
28. Payne, P. W., Sebo, T. J., Doudkine, A., Garner, D., MacAulay, C., Lam, S., LeRiche, J. C., and Palcic, B. Sputum screening by quantitative microscopy: a re-examination of a portion of the National Cancer Institute Cooperative Early Lung Cancer Detection Study. Mayo Clin. Proc., 72: 697-704, 1997.
29. Tockman, M. Advances in sputum analysis for screening and early detection of lung cancer. Cancer Control, 7: 19-24, 2000.
30. Palmisano, W. A., Divine, K. K., Saccomanno, G., Gilliland, F. D., Baylin, S. B., Herman, J. G., and Belinsky, S. A. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res., 60: 5954-5958, 2000.
31. Flehinger, B. J., Melamed, M. R., Zaman M. B. Heelan R. T. Perchick, W. B., and Martini, N. Early lung canceer detection: Results of the initial (prevalence) radiologic and cytologic screening in the Memorial Sloan-Kettering Study. Am. Rev. Respir. Dis., 130: 555-560, 1984.
32. Frost, J. K., Ball, W. C., Levin, M. L., Tockman, M. S., Baker, R. R., Carter, D., Eggleston, J. C., Erozan, Y. W., Gupta, P. R., Khouri, N. F., Marsh, B. R., and Stitik, F. P. Early lung cancer detection: Results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins Study. Am. Rev. Respir. Dis., 130: 549-554, 1984.
33. Fontana, R. S., Sanderson, D. R., Taylor, W. F., Woolner, L. B., Miller, W. E., Muhm, J. R., and Uhlenhopp, M. A. Early lung cancer detection: Results of the initial (prevalence) radiologic and cytologic screening in the Mayo Clinic Study. Am. Rev. Respir. Dis., 130: 561-565, 1984.
34. Kubik, A., Parkin, D. M., Khlat, M., Erban, J., Polak, J., and Adamec, M. Lack of benefit from semi-annual screening for cancer of the lung: follow-up report of a randomized controlled trial on a populatiojn of high-risk males in Czechoslovakia. Int. J. Cancer, 45: 26-33, 1990.
35. Bechtel, J. J., Petty, T. L., and Saccomanno, G. Five year survival and later outcome of patients with X-ray occult lung cancer detected by sputum cytology. Lung Cancer, 30: 1-7, 2000.
36. Archer, P. G., Koprowska, I., McDonald, J. R., Naylor, B., Papanicolaou, G. N., and Umiker, W. O. A study of variability in the interpretation of sputum cytology slides. Cancer Res., 26: 2122-2144, 1966.
37. Holiday, D. B., McLarty, J. W., Farley, M. L., Mabry, L. C., Cozens, D., Roby, T., Waldron, E., Underwood, R. D., Anderson, E., and Culbreth, W. Sputum cytology within and across laboratories. A reliability study. Acta Cytol., 39: 195-206, 1995.
38. Bach, P. B., Kattan, M. W., Thornquist, M. D., Kris, M. G., Tate, R. C., Barnett, M. J., Hsieh, L. J., and Begg, C. B. Variations in lung cancer risk among smokers. J. Natl. Cancer Inst., 95: 470-478, 2003.